Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Skorecki

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
The FEBS Journal|November 13, 2019
Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieuAlok Jha, Vinod Kumar, Shabirul Haque, et al.
JAMA|August 18, 2011
Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal diseaseAsaf Vivante, Arnon Afek, Yael Frenkel-Nir, et al.
The New England Journal of Medicine|March 26, 2010
A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndromeDaniella Magen, Liron Berger, Michael J Coady, et al.
Journal of Hypertension|February 8, 2017
Prehypertension among 2.19 million adolescents and future risk for end-stage renal diseaseAdi Leiba, Gilad Twig, Asaf Vivante, et al.
Lancet (London, England)|February 19, 2024
Moral clarity at WHO needs to be clearerRafael Beyar, Shraga Blazer, Edward Breuer, et al.
Human Genetics|August 12, 2009
Extended Y chromosome haplotypes resolve multiple and unique lineages of the Jewish priesthoodMichael F Hammer, Doron M Behar, Tatiana M Karafet, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2017
Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy DepletionDaniel Granado, Daria Müller, Vanessa Krausel, et al.
Human Genetics|July 17, 2010
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneShay Tzur, Saharon Rosset, Revital Shemer, et al.
Journal of the American Society of Nephrology : JASN|November 13, 2020
Childhood Cancer and the Risk of ESKDRonit Calderon-Margalit, Oren Pleniceanu, Dorit Tzur, et al.
Human Genetics|January 24, 2004
Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populationsDoron M Behar, Daniel Garrigan, Matthew E Kaplan, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
The FEBS Journal|November 13, 2019
Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieuAlok Jha, Vinod Kumar, Shabirul Haque, et al.
JAMA|August 18, 2011
Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal diseaseAsaf Vivante, Arnon Afek, Yael Frenkel-Nir, et al.
The New England Journal of Medicine|March 26, 2010
A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndromeDaniella Magen, Liron Berger, Michael J Coady, et al.
Journal of Hypertension|February 8, 2017
Prehypertension among 2.19 million adolescents and future risk for end-stage renal diseaseAdi Leiba, Gilad Twig, Asaf Vivante, et al.
Lancet (London, England)|February 19, 2024
Moral clarity at WHO needs to be clearerRafael Beyar, Shraga Blazer, Edward Breuer, et al.
Human Genetics|August 12, 2009
Extended Y chromosome haplotypes resolve multiple and unique lineages of the Jewish priesthoodMichael F Hammer, Doron M Behar, Tatiana M Karafet, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2017
Intracellular APOL1 Risk Variants Cause Cytotoxicity Accompanied by Energy DepletionDaniel Granado, Daria Müller, Vanessa Krausel, et al.
Human Genetics|July 17, 2010
Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 geneShay Tzur, Saharon Rosset, Revital Shemer, et al.
Journal of the American Society of Nephrology : JASN|November 13, 2020
Childhood Cancer and the Risk of ESKDRonit Calderon-Margalit, Oren Pleniceanu, Dorit Tzur, et al.
Human Genetics|January 24, 2004
Contrasting patterns of Y chromosome variation in Ashkenazi Jewish and host non-Jewish European populationsDoron M Behar, Daniel Garrigan, Matthew E Kaplan, et al.
Pageof 14